Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding postal ballot notice issued on 08.01.2026.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited submitted copies of newspaper advertisements of its postal ballot notice to NSE and BSE under SEBI (LODR) Regulation 47. The notice was published in Financial Express (English) and Sanjevani (Kannada) on January 9, 2026. The postal ballot seeks shareholder approval for the appointment of Mr. Mukesh Beekamchand (DIN: 11295580) as Non-Executive Independent Director for a 5-year term, via an ordinary resolution. E-voting is being conducted through NSDL, starting January 9, 2026 (9:00 AM) and ending February 7, 2026 (5:00 PM), with EVEN 138066. Mr. Parameshwar G. Bhat has been appointed as Scrutinizer, and results will be declared within two working days of the conclusion of e-voting.
This is a routine regulatory compliance filing confirming the postal ballot process has been formally initiated. Shareholders need to e-vote before February 7, 2026 to approve the appointment of a new Independent Director. A board addition through postal ballot is a normal corporate governance event and is not expected to materially move the stock price.